跳至主要内容
临床试验/JPRN-UMIN000024619
JPRN-UMIN000024619招募中未知

Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonography - Contrast-enhanced ultrasonography for malignant lymphoma

ihon University School of Medicine, Itabashi Hospital0 个研究点目标入组 50 人开始时间: 2016年10月31日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) history of allergy to Sonazoid 2) history of allergy to egg 3) not eligible for this study judged by doctors

研究者

发起方
ihon University School of Medicine, Itabashi Hospital

相似试验

终止
不适用
Assessing the role of Positron Emission Tomography (PET) scanning to assess early response to treatment in advanced breast cancer.Breast Cancer
ACTRN12612001044819Alfred Foundation5
进行中(未招募)
1 期
A new magnetic resonance scanning technology for monitoring therapy effects in patients with Pancreatic cancer.MedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864
EUCTR2016-004491-22-DKDept. Clinical Medicine, Aarhus Universit15
已完成
不适用
Early evaluation for chemotherapy response of lung cancer using a new PET/CT tracer of DNA synthesis.on-small cell lung caner
JPRN-UMIN000012322ational Center for Global Health and Medicine80
已完成
不适用
Early response assessment of induction chemotherapy in acute myeloid leukemia patients using F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT)Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0001293The Catholic University of Korea, St. Vincent's Hospital13
进行中(未招募)
1 期
Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and NeckSquamous Cell Carcinoma (HNSCC) - CAPRAnresectable or Inoperable locally advanced head and neck squamous cellcarcinoma without any prior chemotherapy or radiotherapyMedDRA version: 9.1Level: PTClassification code 10041823Term: Squamous cell carcinoma
EUCTR2008-005702-39-FRGERCOR50